A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature.
El-Sahli S, Hua K, Sulaiman A, Chambers J, Li L, Farah E, McGarry S, Liu D, Zheng P, Lee SH, et al. Cell Death Dis. 2021 Jan 4; 12(1):8. Epub 2021 Jan 4.